Autoimmune heparin‐induced thrombocytopenia of delayed onset: a clinical challenge

Abstract

This case presents that testing PLT-activating antibodies both in the presence and in the absence of current heparin treatment helps to diagnose patients with autoimmune HIT. There is conflicting evidence to refuse PLT transfusion when HIT is complicated with life-threatening bleeding.